Treatment with CNM-Au8 led to clinical improvements in relapsing-remitting MS patients that linked to signs of nerve cell ...

Nicolas Ferreyros discussed central ideas from the Community Oncology Alliance to optimize cancer care in community oncology ...

Portland, Oregon & Vancouver, B.C., April 10, 2025 (GLOBE NEWSWIRE) -- Molecular You, a leading molecular medicine platform ...

Verge Genomics will use digital biomarkers to assess short-term disease progression in an ALS trial testing its VRG50635 ...

Discovery data demonstrates strong sensitivity and specificity in detecting active disease across six different types of substance use disorder ...

Quantum is partnering with Massachusetts General Hospital on a clinical study to test a PET tracer for monitoring response to ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

Trace is partnering with Unlearn as it advances plans for a clinical trial of its treatment candidate that targets the UNC13A ...

A groundbreaking innovation could soon make cancer detection faster, easier, and less invasive. A revolutionary new technology, developed and manufactured in Manchester, could eliminate the need for ...

Cassava will stop developing simufilam for Alzheimer’s this year after a Phase 3 trial failed to improve cognition and daily ...

DMD treatment KER-065 showed a good safety profile in a Phase 1 clinical trial with no serious side effects seen in healthy ...

Longevity experts are mostly over Bryan Johnson's shtick and hope people consider the basics when it comes to taking care of ...